Latest in Highlight
Pharmaceutical company announces formation of $40m global Novartis COVID-19 Response Fund
Breast cancer responsible for about 15% of deaths of tumours
Factories’ revenues amounted to EGP 5bn in November, despite calls for raising prices
The Swiss pharmaceutical giant Novartis has said its net profit slipped 3 percent in the second quarter. It cited tough competition for its top cancer drug by new generic medications in the United States.